Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April July May June August September October November December
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Vice-Chancellor to receive prestigious lifetime achievement award in the United States
2013-05-23

23 May 2013

 - Acceptance Speech

The University of the Free State (UFS) is proud to announce that yet another major international award will be bestowed on the Vice-Chancellor and Rector, Prof Jonathan Jansen.

On 3 June 2013 the Education Africa Lifetime Achievement Award for Africa will be added to the multiple international and local achievements and awards Prof Jansen has received over the past months.

He will receive the award at a gala dinner at the Mandarin Oriental Hotel in New York City, United States. The glamorous event is hosted in collaboration between Education Africa and Brand South Africa. Prof Jansen will join an illustrious list of recipients, including Sir Bob Geldof, Sir Richard Branson and Archbishop Emeritus Desmond Tutu.

“I am deeply humbled by this award which I dedicate to the great teachers of our country, who under difficult conditions make our schools work for children of the poor; they are the real heroes of education," says Prof Jansen.

The Education Africa Lifetime Achievement Award for Africa is a highly regarded recognition on the world stage, awarded to individuals who focus the attention of the global community on the obstacles some of the poorest African nations face.

“He is a pioneering South African educator who is successfully transforming what was once a bastion of apartheid-era segregation and ideology into one of his country’s most inclusive and dynamic institutions of higher learning,” the organisers said in a statement.

As an extra honour to the UFS, one of its Council Members will also receive an award together with Prof Jansen at the ceremony in New York City next month. Ndaba Ntsele, also the Executive Chairman of Pamodzi Gold Limited and President of the South African Black Business Council, will receive the Education Africa Allegiance Award. This award is given to persons for their ‘steadfast support of the organisation [Education Africa] over many years.”

Prof Jansen’s other recent international awards and honours include the Alice and Clifford Spendlove Prize in Social Justice, Diplomacy and Tolerance from the University of California in the US and membership of the Laureate Chapter of the Kappa Delta Pi International Honour Society in Education.

For more information on these as well as the other awards Prof Jansen has recently received, click here.

 

 

 

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept